Successful engraftment of allogeneic PBSC after conditioning with busulfan alone

Bone Marrow Transplantation

Volumn 19, Issue 6, 1997, Pages 621-623

  Majolino, I ^a   Cavallaro, A M ^a   Santoro, A ^a   Catania, P ^a   Cannella, S ^a   Vasta, S ^a   Scime, R ^a  

^a VILLA SOFIA CERVELLO HOSPITAL   (Italy)

Author keywords

Busulfan; Chimerism; Conditioning; PBSC; Transplantation

Indexed keywords

ANTIBIOTIC AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; DOPAMINE; GRANULOCYTE COLONY STIMULATING FACTOR; MICROSATELLITE DNA; STEROID;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BLOOD CELL COUNT; CASE REPORT; FEMALE; GRAFT VERSUS HOST REACTION; HEART FAILURE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LUNG EMBOLISM; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SEPTIC SHOCK; STEM CELL TRANSPLANTATION;

EID: 0030937581     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700696     Document Type: Article

References (12)

1. Santos GW, Tutschka PJ, Brookmeyer R et al. Marrow transplantation for acute non-lymphocytic leukemia after treatment with busulfan and cyclophosphamide. New Engl J Med 1983; 309: 1347-1353.
2. Tutschka PJ, Copelan EA, Klein JP. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 1987; 70: 1382-1388.
3. Tutschka PJ, Santos GW. Bone marrow transplantation in the busulfan-treated rat. Transplantation 1977; 24: 52-62.
4. Bacigalupo A, Piaggio G, Podesta′ M et al. Influence of marrow CFU-GM content on engraftment and survival after allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 15: 221-226.
5. Körbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995; 85: 1655-1658.
6. Dreger P, Suttorp M, Haferlach T et al. Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation. Blood 1993; 81: 1404-1407.
7. Aversa F, Tabilio A, Terenzi A et al. Successful engraftment of T-cell-depleted haploidentical three loci incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994; 84: 3948-3955.
8. Schmitz N, Dreger P, Suttorp M et al. Primary transplantation of allogeneic peripheral blood cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995; 85: 1666-1672.
9. Majolino I, Saglio G, Scimè R et al. High incidence of chronic GVHD after primary allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies. Bone Marrow Transplant 1996; 17: 555-560.
10. Mackinnon S, Barnett L, Heller G, O'Reilly RJ. Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia. Blood 1994; 83: 3409-3416.
11. Avalos BR, Klein JL, Kapoor N, Copelan EA. Allogeneic bone marrow transplantation following busulfan and 90 mg/kg of cyclophosphamide. Bone Marrow Transplant 1993; 12: 655-658.
12. Yu C, Storb R, Mathey B et al. DLA-identical bone marrow grafts after low-dose total body irradiation: effects of high-dose corticosteroids and cyclosporine on engraftment. Blood 1995; 86: 43-76.